Corporate GovernanceJul 2, 2026, 04:28 PM
Arcadia Biosciences Updates CEO 2025 Pay, Sets 2026 Annual Meeting
AI Summary
Arcadia Biosciences, Inc. updated its 2025 Summary Compensation Table to reflect a discretionary cash bonus payment of $169,000 to CEO Thomas J. Schaefer for the 2025 year, bringing his total compensation to $473,058. This update follows a previous filing where the bonus amount was not yet determinable. Additionally, the company announced that its 2026 annual meeting of stockholders will be held on September 10, 2026, a change of more than 30 calendar days from the anniversary of the 2025 meeting.
Key Highlights
- CEO Thomas J. Schaefer's 2025 total compensation updated to $473,058.
- CEO Thomas J. Schaefer received a discretionary cash bonus of $169,000 for 2025.
- No other named executive officers received a bonus payment for 2025.
- Former CFO Mark Kawakami's 2025 total compensation was $274,428.
- The 2026 Annual Meeting of stockholders is scheduled for September 10, 2026.
- The annual meeting date changed by more than 30 days from the 2025 anniversary.
Price Impact
More from RKDA